Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...

- Yapan can now support end-to-end development and manufacturing of RNA, DNA and gene therapy products starting from plasmids - Expansion inaugurated by Telangana Minister Kalvakuntla Taraka Rama Rao ...

Process development is the exercise of creating new and improved manufacturing methods, optimizing them in terms of time and financial efficiency while maintaining regulatory compliance and product ...

State Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture has the following research output in the current window (1 October 2024 - 30 ...

LGM Pharma’s Expanded Contract Development and Manufacturing Organization (CDMO) Capabilities Will Enable Customers to Accelerate and Optimize the New Product Pathway from Early Development Through ...

PharmTech recently spoke with Saharsh Davuluri, Vice Chairman and Managing Director, Neuland Labs, to get his perspective on trends that shaped pharmaceutical development and manufacturing in 2025 and ...

Medicine makers need to get better at math. Improved mathematical modeling would accelerate the move toward automated processes, cut production times, and reduce costs. Researchers Francesco Destro, ...

Piramal Pharma Limited (PPL) reports that Yapan Bio has expanded its capabilities with a new process development facility at Genome Valley, Hyderabad, India. PPL holds a strategic minority stake in ...

Variations on standard tablets, which can be distinguished by both colour and shape.— Photo by Ragesoss (CC BY-SA 2.0) Variations on standard tablets, which can be distinguished by both colour and ...

Donna Conroy, MS is Founder/CEO of SciMar ONE, Inc. a technology company building AI-based SaaS solutions for the pharmaceutical industry. Investing time and resources is clearly a long-term strategy ...

VCU professor Frank Gupton, Phlow’s co-founder, is shown at a lab in VA Bio+Tech Park, Richmond, on Tuesday, May 19, 2020. Richmond-based pharmaceutical development company Phlow Corp. has formed a ...